Cereno Scientific enters collaboration with University of Michigan
Cereno Scientific today announced that the company enters a collaboration agreement with the University of Michigan in Ann Arbor, USA. On behalf of Cereno Scientific, Dr. Michael Holinstat, who is active at the University, is to initiate preclinical studies with compounds from Cereno’s HDACi development program. The studies will begin in June and investigate anti-thrombotic properties using in vitro and in vivo model systems.“We welcome the collaboration with the University of Michigan and Mike Holinstat and are pleased that we are now further strengthening our preclinical expertise and